Pharmagen Inc (PHRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 9337 FRASER AVE.
SILVER SPRING, MD 20910
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 10 - Metal Mining (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2014
MRQ
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 226323
Cash and cash equivalents 226323
Receivables 368636
Inventory, net of allowances, customer advances and progress billings137147
Inventory 137147
Prepaid expense and other current assets282
Other undisclosed current assets 149198
Total current assets: 8791,586
Noncurrent Assets
Property, plant and equipment 38391
Intangible assets, net (including goodwill)1,196
Goodwill  1,196
Other undisclosed noncurrent assets 2025
Total noncurrent assets: 4031,312
TOTAL ASSETS: 1,2822,897
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 1,379779
Other undisclosed accounts payable and accrued liabilities 1,379779
Debt 770750
Derivative instruments and hedges, liabilities 2,114 
Due to related parties 191148
Other undisclosed current liabilities 3,644757
Total current liabilities: 8,0992,435
Noncurrent Liabilities
Long-term debt and lease obligation, including: 5503
Long-term debt, excluding current maturities  503
Capital lease obligations 42 
Other undisclosed long-term debt and lease obligation (38) 
Other undisclosed noncurrent liabilities 7652,652
Total noncurrent liabilities: 7703,155
Total liabilities: 8,8695,589
Equity
Equity, attributable to parent, including: (7,712)(2,692)
Preferred stock  3
Common stock 434381
Additional paid in capital 1,478166
Accumulated deficit (9,148)(3,148)
Other undisclosed equity, attributable to parent (475)(94)
Other undisclosed equity 125 
Total equity: (7,587)(2,692)
TOTAL LIABILITIES AND EQUITY: 1,2822,897

Income Statement (P&L) ($ in thousands)

3/31/2014
TTM
12/31/2013
12/31/2012
Revenues 4,8133,937
Revenue, net 4,813323
Cost of revenue (1,768)(2,996)
Cost of goods and services sold (1,768)(2,996)
Other undisclosed gross profit  323
Gross profit: 3,0451,265
Operating expenses (6,657)(3,361)
Other operating income (expense), net
(Other Expenses)
 2,389(675)
Other undisclosed operating income (loss) (2,389)675
Operating loss: (3,612)(2,096)
Nonoperating income (expense)
(Investment Income, Nonoperating)
 633(90)
Interest and debt expense (3,008)(245)
Loss from continuing operations: (5,986)(2,431)
Loss before gain (loss) on sale of properties: (5,986)(2,431)
Other undisclosed net loss (14)(340)
Net loss: (6,001)(2,771)
Net loss attributable to noncontrolling interest (6,458) 
Other undisclosed net income attributable to parent 6,458 
Net loss available to common stockholders, diluted: (6,001)(2,771)

Comprehensive Income ($ in thousands)

3/31/2014
TTM
12/31/2013
12/31/2012
Net loss: (6,001)(2,771)
Comprehensive loss: (6,001)(2,771)
Comprehensive income, net of tax, attributable to noncontrolling interest 6,458 
Comprehensive income (loss), net of tax, attributable to parent: 457(2,771)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: